Health and Medical

SUMMA 2.2 is a comprehensive real-time continuous glucose monitoring platform that provides end-to-end CGM data management. The platform features modular solutions designed to support various trial designs, from direct-to-patient studies to hybrid and traditional clinical trial formats.

SUMMA 2.2

Pharmaceutical

Manufacturing and Industry

Precision Digital Health, Inc

California

Biopharma

Manufacturing

Precision Digital Health offers a suite of services to support clinical trial data management, including platform implementation, data integration, regulatory compliance support, and vendor management.

Clinical Trial Data Management Services

Other products/services from Precision Digital Health, Inc

SUMMA 2.2

N/A